The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of RecurIndex (RI) for patients with early-stage breast cancer enrolled in a Taiwanese multicenter study.
 
Yi-Hsuan Lee
No Relationships to Disclose
 
Nicolas Pennarun
Consulting or Advisory Role - Amwise
 
Ling-Ming Tseng
No Relationships to Disclose
 
Po-Sheng Yang
No Relationships to Disclose
 
Ji-An Liang
No Relationships to Disclose
 
Chia-Ming Hsieh
No Relationships to Disclose
 
Yuan-Ching Chang
No Relationships to Disclose
 
Ming-Yang Wang
No Relationships to Disclose
 
Kuan-Hui Shih
Employment - Amwise
 
Skye Hung-Chun Cheng
Employment - Amwise (I)
Leadership - Amwise
Stock and Other Ownership Interests - Amwise
Patents, Royalties, Other Intellectual Property - Inventor of this technology and owned this IP
Travel, Accommodations, Expenses - Amwise
 
Chiung-Sheng Huang
Honoraria - Amgen; AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Pfizer; Roche
Speakers' Bureau - Amgen; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche